Secondary sulfonylurea failure: Comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary sulfonylurea failure: Comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide

Published:2005-12 Issue:3 Volume:70 Page:291-297
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Satoh Jo,Takahashi Kazuma,Takizawa Yumiko,Ishihara Hisamitsu,Hirai Masashi,Katagiri Hideki,Hinokio Yoshinori,Suzuki Susumu,Tsuji Ichiro,Oka Yoshitomo

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance;Polonsky;N. Engl. J. Med.,1996

2. Oral antihyperglycemic therapy for type 2 diabetes: scientific review;Inzucchi;JAMA,2002

3. Sulfonylureas;Zimmerman;Endocrinol. Metab. Clin. North Am.,1997

4. The sufphonylurea receptor may be an ATP-sensitive potassium channel. The sulphonyl urea receptor may be an ATP-sensitive potassium channel;Sturgess;Lancet,1985

5. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas;Harrower;J. Diabetes Complications,1994

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus;Diabetes mellitus;2024-09-04

2. Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years;Diabetes Research and Clinical Practice;2024-08

3. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review;Diabetes Therapy;2024-06-27

4. Evaluating gliclazide for the treatment of type 2 diabetes mellitus;Expert Opinion on Pharmacotherapy;2022-11-10

5. The role of sulfonylureas in the treatment of type 2 diabetes;Expert Opinion on Pharmacotherapy;2021-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3